Menu
Not yet recruiting NCT06785831

NutriPlant - Opportunities for Increasing Consumption of Local Fruits and Vegetables

No phase Interventional Functional Constipation Irritable Bowel Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Psyllium, Sauerkraut, Fresh apples, Dried apples.
Who it may be relevant to
Registry conditions: Functional Constipation, Irritable Bowel Syndrome. Basic parameters: 18 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Slovenia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Opportunities for Increasing Consumption of Local Fruits and Vegetables in Slovenian Population (NutriPlant)

Overview

The effects of different foods to normal bowel function in adult population will be investigated. A randomised controlled intervention trial will be conducted on about 120 (30 per group) adult (18-70 years) subjects with functional constipation and irritable bowel syndrome with constipation according to the IV. Rome criteria. At least one week before inclusion in the study, patients will stop taking laxatives and other anti-constipation medications. Subjects will be randomly selected to consume one of the test foods (fresh apples, dried apples, sauerkraut) or the active control (psyllium) in the equivalent amount of 3 g of fiber per day for 4 weeks. Subjects will be asked not to change their lifestyle habits, such as diet and physical activity level, and not to take oral laxatives during the period of participation in the study.

Interventions

  • Other Psyllium
    Participants will once daily consume predefined amount of psyllium, corresponding to 3 g of dietary fibre, for 28 days.
  • Other Sauerkraut
    Participants will once daily consume predefined amount of sauerkraut, corresponding to 3 g of dietary fibre, for 28 days.
  • Other Fresh apples
    Participants will once daily consume predefined amount of fresh apples, corresponding to 3 g of dietary fibre, for 28 days.
  • Other Dried apples
    Participants will once daily consume predefined amount of dried apples, corresponding to 3 g of dietary fibre, for 28 days.

Primary outcome measures

  • Change in frequency of complete spontaneous bowel movements (CSBM) / week [Time frame: fourth week vs pre-intervention]

Eligibility criteria

  • Inclusion criteria:
  • Signed informed consent of the participant to participate in the study
  • Age between 18 and 70 years
  • Functional constipation or irritable bowel syndrome
  • Expressed willingness to eat the investigated food daily (sauerkraut, apples, dried apples or psyllium; period of four weeks)
  • Exclusion criteria:
  • Known allergy to the investigated foods (fresh apples, dried apples, sauerkraut or psyllium)
  • Pregnancy or breastfeeding
  • Previous gastrointestinal surgery with the exception of cholecystectomy and appendectomy
  • Other gastrointestinal diseases (chronic inflammatory bowel disease, celiac disease, gastroparesis, etc.)
  • Serious chronic diseases
  • Introduction of extensive changes in diet or physical activity in the last 4 weeks before the inclusion examination
  • Regular use of laxatives or inability to stop using laxatives for the duration of the study
  • Concurrent participation in another study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Slovenia · 1 center
  • UKC Ljubljana — Ljubljana

Identifiers

NCT: NCT06785831 · KME 0120-242/2024-2711-4 · L7-50154 · L7-50154

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗